Parkinson's disease (PD) patients often exhibit impaired regulation of heart rate by the autonomic nervous system (ANS) that may precede motor symptoms in many cases. Results of autopsy studies suggest that brainstem pathology, including the accumulation of ␣-synuclein, precedes damage to dopaminergic neurons in the substantia nigra in PD. However, the molecular and cellular mechanisms responsible for the early dysfunction of brainstem autonomic neurons are unknown. Here we report that mice expressing a mutant form of ␣-synuclein that causes familial PD exhibit aberrant autonomic control of the heart characterized by elevated resting heart rate and an impaired cardiovascular stress response, associated with reduced parasympathetic activity and accumulation of ␣-synuclein in the brainstem. These ANS abnormalities occur early in the disease process. Adverse effects of ␣-synuclein on the control of heart rate are exacerbated by a high energy diet and ameliorated by intermittent energy restriction. Our findings establish a mouse model of early dysregulation of brainstem control of the cardiovascular system in PD, and further suggest the potential for energy restriction to attenuate ANS dysfunction, particularly in overweight individuals. Published by Elsevier Inc.
Introduction
Parkinson's disease (PD) clinical findings and neuropathological staging of PD suggest that autonomic nervous system (ANS) dysfunction and brainstem pathology, including the accumulation of ␣-synuclein, precedes midbrain dopaminergic pathology and motor symptoms (Buob et al., 2010; Müller et al., 2005) . Symptoms of ANS dysfunction in prodromal PD include constipation associated with reduced parasympathetic activation of gut motility (Savica et al., 2009) , and orthostatic hypotension mediated by degeneration of sympathetic neurons (Jain and Goldstein, 2012) . PD patients also often exhibit impaired autonomic regulation of sweating, urination, pupillary responses to light, and hypothalamic regulation of endocrine organs (Jain, 2011) . Heart rate (HR) is modulated by cholinergic parasympathetic neurons of the brainstem dorsal motor nucleus of the vagus (DMNV) and nucleus ambiguous, and by noradrenergic sympathetic neurons. Self-aggregation and accumulation of ␣-synuclein is implicated in the dysfunction and degeneration of midbrain dopaminergic neurons in PD, but the role of ␣-synuclein in ANS dysfunction in PD is unknown. However, two recent studies have documented impaired intestinal motility associated with ␣-synuclein accumulation in enteric ANS neurons, and these abnormalities preceded motor dysfunction (Hallett et al., 2012; Kuo et al., 2010) . In the present study we describe another ANS ab-normality in ␣-synuclein mutant mice involving impaired brainstem cholinergic regulation of HR.
Epidemiological data suggest that being overweight in midlife is a risk factor for PD (Hu et al., 2006) . In addition, dietary energy restriction protects midbrain dopaminergic neurons and improves functional outcome in neurotoxinbased animal models of PD (Duan and Mattson, 1999; Maswood et al., 2004) , whereas a high energy diet is detrimental (Morris et al., 2010) . Intermittent energy restriction is known to enhance brainstem parasympathetic activity, while high energy diets have the opposite effect (Thayer et al., 2010; Wan et al., 2003) . Here we describe ANS dysfunction in ␣-synuclein mutant mice that is exacerbated by a high calorie diet (HCD) and ameliorated by intermittent energy restriction (intermittent fasting; IF). These findings provide a model for future studies of the molecular and cellular mechanisms responsible for ANS dysfunction in PD, and their potential modification by therapeutic interventions.
Methods

Animals and diets
Male B6.Cg-Tg(Thy-1-SNCA*A53T) M53Sud/J (SNCA) mice (Chandra et al., 2005) (Jackson Laboratories, Bar Harbor, ME, USA) and wild type (WT) littermates were housed under a 12-hour light/dark cycle. SNCA mice express A53T mutant human ␣-synuclein under the control of the murine Thy-1 promoter and exhibit ␣-synuclein accumulation in the midbrain, and age-dependent motor impairment (Chandra et al., 2005) . No previous studies have described autonomic deficits in this mouse model of PD. Mice were maintained on either standard chow or a high calorie diet (Dyets 101842; Dyets, Inc., Bethelem, PA, USA; with water containing 11% of a fructose/glucose mix) (Stranahan et al., 2008) , or were maintained on an alternate day fasting diet (Arumugam et al., 2010) . Weight and food intake were recorded throughout the study. All procedures were approved by the Institutional Animal Care and Use Committee of the National Institute on Aging.
Telemetry
Telemetry transmitters were surgically implanted as described previously (Wan et al., 2003) at 8 weeks to continuously monitor biological parameters in the mice. Briefly, a transmitter, TA10ETA-F20 (Data Sciences International, St. Paul, MN, USA), which monitors electrocardiogram, core body temperature, and general activity, was surgically implanted in each of the mice. Two biopotential leads were routed subcutaneously lateral to midline of the chest and secured to chest muscles with silk sutures (Ethicon, Cornelia, GA, USA). Telemetry data were continuously recorded in 2.5-minute bins, every 10 minutes. Mice were implanted with transmitters at 2 months of age and allowed to recover for a month before beginning recording. Baseline values for HR, activity, and temperature were recorded in a preliminary group of WT controls (n ϭ 8) and SNCA (n ϭ 8) mice to determine the changes in these parameters throughout the lifespan, and to determine the period in which to apply the diets. In a second group of mice, after a 4-week recovery period, the mice were randomly assigned to 1 of 3 diet groups: standard chow ad libitum (AL; n ϭ 12), HCD ad libitum (n ϭ 12), or alternate day fasting with standard chow (IF; n ϭ 12). Forty-eight-hour baseline recordings were made weekly to monitor changes in HR, activity, and temperature throughout the study (see Fig. 1 for experimental design).
At 12 and 24 weeks of age, all diet groups underwent restraint stress (n ϭ 8 per group). Baseline HR was recorded for 30 minutes. Mice were then individually restrained in Fig. 1 . Experimental design. Mice were implanted with telemetry transmitters at 8 weeks of age. After 4-week recovery, they were divided into standard chow ad libitum (AL), high calorie diet (HCD), and intermittent fasting (IF) diet groups. At 12 weeks, 24 weeks and at 32-48 weeks (at the expression of late symptomatic motor impairment), autonomic assessment was made, and tissues were collected. Forty-eight-hour baseline parameters were recorded weekly throughout the study.
their home cage using a modified plastic DecapiCone Restrainer (Braintree Scientific, Inc., Braintree, MA, USA) for 1 hour; HR was recorded continuously.
Drug treatments
Autonomic blockade was performed by intraperitoneal injection of the mAchR blocker atropine methyl nitrate (parasympathetic blockade; 2 mg/kg), the ␤-1 adrenergic receptor blocker atenolol (sympathetic blockade; 2 mg/kg), or the nicotinic acetylcholine receptor blocker hexamethonium bromide (ganglionic blockade; 30 mg/kg). Preliminary tests with intraperitoneal injection of phosphate-buffered saline determined that HR returned to baseline levels within 30 minutes after injection. Therefore, change in HR was assessed as the difference between the averaged HR for 30 minutes before injection and the averaged HR between 45 and 60 minutes after injection.
Immunoblot analysis
The brain was rapidly removed on ice, and the medulla was dissected and flash frozen. To prepare the tissue for immunoblot analysis it was homogenized in radioimmunoprecipitation assay buffer with protease inhibitors on ice. Protein concentrations were determined using a Bradford assay. Immunoblots were performed using 40 g of total protein extract separated on 4%-12% bis-Tris gels and then transferred electrophoretically to nitrocellulose membranes. Membranes were blocked with 5% milk in Tris-buffered saline-t, washed in Tris-buffered saline-t and incubated overnight at 4°C in an antibody to ␣-synuclein (LB509; Abcam, Cambridge, MA, USA) (1:500), or actin (SigmaAldrich, St. Louis, MO, USA). Membranes were then incubated in a secondary antibody solution for 30 minutes (1: 5000, then in the presence of horseradish peroxidaseconjugated anti-mouse IgG) for 30 minutes. The optical density of immunoreactive bands was detected and quantified by chemiluminescence using the electrochemiluminescence system and results were normalized to actin, averaged, and compared for each age-matched group of SNCA mice and WT littermates.
Quantification of DMNV cells
Brain slices (40 m) were stained with cresyl violet after being mounted sequentially at 120 m intervals traversing the entire brainstem to ensure that the entire length of the DMNV was counted. All neurons in the DMNV were counted unilaterally in a blinded manner (n ϭ 4 per diet group).
Statistical analyses
All data are expressed as mean Ϯ standard error. Data were analyzed by 2-way analysis of variance with Bonferroni's post hoc test and Student t test for individual comparisons between groups using GraphPad version 5 (GraphPad Software, Inc., San Diego, CA, USA); significance was set at p Ͻ 0.05.
Results
PD patients exhibit altered autonomic function and heart rate control, often preceding motor impairment (Jain, 2011) . To test whether a transgenic mouse model of PD, which overexpresses human mutant A53T ␣-synuclein, also exhibits altered autonomic control of HR, SNCA mice, and WT littermates were implanted with telemetry transmitters which monitor HR, home cage activity, and core body temperature. Consistent with a previous study (Hu et al., 2006) , the lifespan of SNCA mice is between 6 and 10 months of age ( Supplementary Fig. 1 ). The HR of young SNCA mice (n ϭ 12; 3 months; Fig. 1 ), was significantly elevated compared with WT mice during the light and dark periods (Fig. 2) . The elevated HR in SNCA mice was not due to higher activity levels, as the activity of SNCA mice was similar to WT mice (Fig. 3) . In addition, the body temperature of SNCA mice was similar to WT mice (Fig.  4) . Therefore, this suggests that SNCA mice exhibit elevated HR, independent of their activity.
High calorie diets and obesity are associated with cardiovascular dysfunction in humans, and can exacerbate dopaminergic degeneration in some animal models of PD (Bousquet et al., 2012; Morris et al., 2010) . In contrast, caloric restriction is associated with improved cardiovascular health, and can protect dopaminergic neurons in mouse (Duan and Mattson, 1999) and monkey (Maswood et al., 2004 ) models of PD. Therefore, we tested whether intermittent fasting could improve, and high calorie diet could exacerbate, the abnormal HR in SNCA mice. Mice were assigned to ad libitum control (AL; n ϭ 12), intermittent (alternate day) fasting (IF; n ϭ 12), or high calorie (high fat diet plus 11% fructose/glucose in the drinking water) diets (HCD; n ϭ 12). WT mice on an HCD rapidly gained weight, while SNCA mice failed to gain weight on the HCD diet ( Supplementary Fig. 2 ). In contrast, the weight of mice on the IF diet was reduced. Food intake for mice on the HCD was significantly reduced (Supplementary Fig. 3 ), consistent with consumption of a calorie-dense diet (Martin et al., 2007) . Consistent with other reports, IF mice consumed less overall average food than those on the AL diet (Duan et al., 2003; Martin et al., 2007) . At 4, 8, and 12 weeks after diet initiation (a time point designated as early symptomatic [ES] with regard to HR changes) telemetry results revealed highly significant reductions in HR in WT and SNCA mice on IF compared with AL diets (Fig. 2) . Whereas IF ameliorated the abnormal elevation of HR in SNCA mice, HCD significantly exacerbated the elevated HR in SNCA mice (Fig. 2) . As expected from previous studies (Wan et al., 2003) , WT mice in the IF group exhibited a significant reduction of body temperature on the fasting days (Fig. 4) . The body temperature of the SNCA mice was also reduced during the fasting days, by amounts similar to that of WT mice.
To determine the physiological basis of the elevated HR caused by mutant ␣-synuclein, we tested autonomic control of heart rate in AL, IF, and HCD mice. We measured HR in WT and SNCA mice in the presence of antagonists of cholinergic (atropine) or ␤-adrenergic (atenolol) receptors. At young, ES, and disease end stage ages, AL SNCA mice exhibited a significantly reduced HR elevation in response to atropine compared with WT mice (Fig. 5A) , suggesting impaired parasympathetic activity to the heart. The HR response to atropine was reduced in WT mice on HCD, but unaffected by IF. Interestingly, SNCA mice on the IF diet exhibited reduced parasympathetic input on feeding days, but normal parasympathetic activity was restored on fasting days (Fig. 5A) . At young and ES ages, atenolol reduced HR to a greater degree in SNCA mice, and the HCD resulted in significantly reduced HR responses to atenolol in SNCA compared with WT mice (Fig. 5B) , suggesting altered sympathetic activity to the heart. The intrinsic HR, determined by ganglionic blockade with hexamethonium bromide, was not different in young and ES SNCA mice fed AL, but was significantly reduced in disease end stage SNCA mice and ES SNCA mice on the HCD (Fig. 5C ). Therefore, SNCA mice exhibit impaired autonomic control of HR, and this is exacerbated by HCD and partially restored by IF.
PD patients may exhibit a reduced sympathetic cardiac response to stress (Nakamura et al., 2010) . To test whether SNCA mice also exhibit dysregulation of HR control during stress, we exposed mice to restraint stress. Restraint stress is a well-characterized paradigm which elevates HR and is mediated by central cardiovascular control (Shapiro et al., 1993; Wan et al., 2003) . During restraint stress, the change in HR in SNCA mice was significantly less than the HR response to stress in WT mice ( Supplementary Fig. 4 ). The SNCA mice on the AL, IF, and HCD each attained only a very small increase in HR during restraint stress. This suggests that similar to PD patients, SNCA mice also exhibit altered HR responses to stress.
Finally, we evaluated ␣-synuclein protein levels in the brainstems of WT and SNCA mice in AL, IF, and HCD groups. Immunoblot analysis demonstrated high amounts of ␣-synuclein in the brainstems of SNCA mice compared with WT mice. In SNCA mice the levels of ␣-synuclein increased with age, and were not significantly affected by HCD or IF (Fig. 6A and B ). There were no significant differences in DMNV cell number in WT and SNCA mice, nor did age or diet affect the number of DMNV cells (Fig.  6C) . Collectively, these findings suggest that IF preserves DMNV cell function despite the presence of mutant ␣-synuclein, a finding similar to a study in a mouse model of Alzheimer's disease where IF did not reduce amyloid ␤-peptide accumulation, but nevertheless preserved cognitive function (Halagappa et al., 2007) . On the other hand, the HCD exacerbated the impairment of autonomic control of HR caused by mutant ␣-synuclein, via a mechanism that apparently involves increased vulnerability of parasympathetic brainstem neurons to the ␣-synuclein (i.e., a mechanism downstream of ␣-synuclein accumulation).
Discussion
The brainstem ␣-synuclein pathology and imbalance of autonomic regulation of HR early in the disease process in SNCA mice demonstrated here is comparable with the early brainstem pathology and ANS dysfunction that occurs in humans with PD (Braak et al., 2003; Ghebremedhin et al., 2009) . Our findings suggest an adverse effect of mutant ␣-synuclein on parasympathetic (cholinergic) neurons in the brain stem. The latter finding is consistent with a recent report demonstrating ␣-synuclein pathology in the efferent DMNV axons that innervate the gut (Noorian et al., 2012) . The brainstem pathology in PD is not limited to the DMNV. PD patients exhibit damage to noradrenergic neurons in the locus coeruleus (Chan-Palay and Asan, 1989; Remy et al., 2005) and serotonergic neurons in the raphe nucleus (Basso and Evinger, 1996; Halliday et al., 1990) . The locus coeruleus is also adversely affected in mouse models of familial PD, including ␣-synuclein transgenic mice (Sotiriou et al., 2010) and Parkin-deficient mice (Von Coelln et al., 2004) . Additional findings suggest that deficits of noradrenergic and serotonergic signaling contribute to psychiatric symptoms and motor deficits in PD patients and animal models (Huot et al., 2011; Rodriguez-Oroz et al., 2009; Rommelfanger et al., 2007) . Collectively, the available data suggest that the accumulation of ␣-synuclein in brainstem neurons occurs early in PD and contributes to both peripheral (ANS) manifestations (constipation, aberrant HR regulation, and others) and central nervous system manifestations (anxiety, depression, and motor dysfunction) of the disease.
We found that energy intake modifies ANS dysfunction in SNCA mice, with energy restriction reversing the abnormalities and a high energy diet exacerbating the disease process. It is believed that energy intake might affect the vulnerability of neurons during aging by either increasing . Autonomic dysfunction in SNCA mice is exacerbated by a high energy diet, and restored by intermittent energy restriction. (A) Change in heart rate after intraperitoneal (i.p.) injection of atropine (2 mg/kg) indicates that parasympathetic activity to the heart is significantly reduced in SNCA mice before initiation of diets (PS; 3 months). Twelve weeks after diet initiation, high calorie diet (HCD) significantly reduced parasympathetic activity in wild type (WT) mice, without changing parasympathetic input in SNCA mice. Whereas on feeding days SNCA mice on intermittent fasting (IF) exhibit reduced parasympathetic input to the heart, this activity is restored on fasting days (right panel). Parasympathetic activity remains reduced at disease end stages (LS). (B) Sympathetic activity is significantly elevated in SNCA mice at presymptomatic (PS) stages, before diet initiation (3 months), as assessed by i.p. administration of atenolol (2 mg/kg). Sympathetic activity remains significantly elevated in SNCA mice at 24 weeks (ES). Whereas HCD increased sympathetic input in WT mice, it was significantly decreased in SNCA mice. Sympathetic activity in SNCA mice following IF is restored, and is similar to WT mice (right panel). (C) Intrinsic heart rate (HR) is not different between SNCA and WT mice at young (PS) or ES stages, as assessed by i.p. injection of hexamethonium bromide (30 mg/kg). However, at LS stages, intrinsic heart rate is significantly reduced in SNCA mice. The intrinsic heart rate of mice maintained on HCD was reduced compared with WT mice, similar to LS mice. * p Ͼ 0.05; ** p Ͼ 0.01; n ϭ 10 per group. (energy restriction) or decreasing (energy excess) the production of neurotrophic factors including brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) (Arumugam et al., 2010; Maswood et al., 2004; Morris et al., 2010) . Both BDNF and GDNF can enhance the cholinergic phenotype (Brodski et al., 2002; Yang et al., 2002) , suggesting roles for 1 or both of these neurotrophic factors in the adverse effects of ␣-synuclein and a high energy diet, and the beneficial effects of energy restriction, on ANS brainstem neurons. Indeed, recent findings suggest that BDNF signaling in brainstem cholinergic neurons can enhance parasympathetic activity resulting in a reduction of heart rate and improved cardiovascular stress adaptation (Griffioen et al., 2012) . If similar mechanisms occur in humans, then intermittent energy restriction could mitigate early brainstem ANS dysfunction in PD. PD patients often exhibit abnormalities in sweating and reactivity of blood vessels to changes in body temperature (Goetz et al., 1986) . We found no evidence for disturbed thermoregulation in the SNCA mice, suggesting that either ␣-synuclein does not accumulate in the (hypothalamic) neurons that control body temperature, or those neurons are not adversely affected by the mutant ␣-synuclein. In addition, the SNCA mice exhibited levels of daily activity that were similar to those of WT mice. These findings suggest that ANS control of HR becomes perturbed at early stage in the disease process in SNCA mice, during which time there are no discernible abnormalities of locomotor activity or thermoregulation.
Our findings establish an animal model for early brainstem ANS dysfunction in PD. Measuring HR and HR variability as a "readout" of ANS functional status (Mager et al., 2006; Wan et al., 2003) provides the opportunity to better understand the relationships between perturbed activity in brainstem neurons and a range of abnormalities in PD, including disturbed circadian rhythms, stress responses, and energy metabolism. In addition, this model can be used to understand the molecular and cellular mechanisms by which ␣-synuclein impairs the function of ANS neurons. Moreover, the normalization of ANS function in SNCA mice by intermittent fasting provides proof-of-principle evidence that this model of ANS dysfunction in PD can be used to evaluate the therapeutic efficacy of interventions designed to prevent or treat PD.
